Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

21.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 82.00
  • 52 Week Low: 17.50
  • Currency: UK Pounds
  • Shares Issued: 95.31m
  • Volume: 184,683
  • Market Cap: £20.49m
  • RiskGrade: 410

Regulatory News

Notice of Full Year Results 08-Apr-2024 07:00 RNS
Exercise of Options and Total Voting Rights 19-Mar-2024 14:47 RNS
Clinical development update 31-Jan-2024 07:00 RNS
Appointment of Nominated Adviser and Sole Broker 22-Jan-2024 07:00 RNS
Year End Business Update 04-Jan-2024 07:00 RNS
Grant of Share Options 20-Oct-2023 07:00 RNS
Director/PDMR Shareholding 19-Oct-2023 07:00 RNS
XF Pipeline Update Meeting 17-Oct-2023 07:01 RNS
Publication of new microbiological data for XF-73 17-Oct-2023 07:00 RNS
Director/PDMR Shareholding 10-Oct-2023 07:00 RNS
Director/PDMR Shareholding 04-Oct-2023 12:34 RNS
Notice of XF Pipeline Update Meeting 27-Sep-2023 07:00 RNS
Interim Results 20-Sep-2023 07:00 RNS
Notice of Interim Results 23-Aug-2023 07:00 RNS
Publication of new data for XF-73 31-Jul-2023 12:01 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 21.50p
Change Today -0.50p
% Change -2.27 %
52 Week High 82.00
52 Week Low 17.50
Volume 184,683
Shares Issued 95.31m
Market Cap £20.49m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.11% below the market average33.11% below the market average33.11% below the market average33.11% below the market average33.11% below the market average
58.49% below the sector average58.49% below the sector average58.49% below the sector average58.49% below the sector average58.49% below the sector average
Price Trend
78.21% below the market average78.21% below the market average78.21% below the market average78.21% below the market average78.21% below the market average
22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
16:29 2,000 @ 21.08p
16:29 5,000 @ 21.10p
16:24 2,102 @ 21.50p
16:24 113 @ 22.00p
16:24 1,398 @ 21.50p

Destiny Pharma Key Personnel

CEO Chris Tovey

Top of Page